COPD: Pathophysiology, Phenotypes, and Management Strategies

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/28

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 11:03 AM on 5/14/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

29 Terms

1
New cards

What does GOLD define as Chronic Obstructive Pulmonary Disease (COPD)?

A common, preventable and treatable disease characterized by persistent respiratory symptoms and airflow limitation.

2
New cards

What are the two main causes of COPD?

A mixture of small airways disease and parenchymal destruction (emphysema).

3
New cards

What is a key feature of the bronchodilator reversibility test in COPD?

In COPD, there is only a negative bronchodilator reversibility test.

4
New cards

List typical symptoms of COPD.

Chronic cough, sputum, breathlessness, wheezing, and frequent chest infections.

5
New cards

What age group is most commonly affected by COPD?

Individuals over 35 years, although symptoms can start earlier.

6
New cards

What are some signs of COPD?

Hyperexpanded chest, quiet breath and heart sounds, prolonged expiratory phase, low oxygen saturations, and digital clubbing.

7
New cards

What are the complications associated with COPD?

Pulmonary hypertension, cor pulmonale, bacterial infections, and weight loss.

8
New cards

What are the primary risk factors for developing COPD?

Smoking, occupational dusts and chemicals, indoor air pollution, and genetics.

9
New cards

How does smoking contribute to COPD?

Smoking is implicated in chronic bronchitis and emphysema, with an estimated 15-50% of smokers developing COPD.

10
New cards

What is the MRC Dyspnoea Scale?

A scale ranging from 0 to 4 that assesses the severity of breathlessness in COPD patients.

11
New cards

What is the purpose of the COPD Assessment Test (CAT)?

To measure the impact of COPD on a patient's life, with scores ranging from 0-40.

12
New cards

What spirometry result confirms a diagnosis of COPD?

FEV1/FVC < 0.7 without SABA reversibility.

13
New cards

What is the primary goal of COPD management?

To prevent disease progression, reduce mortality, and improve quality of life.

14
New cards

What are the main components of COPD management?

Smoking cessation, pulmonary rehabilitation, vaccinations, oxygen therapy, and pharmacological treatments.

15
New cards

What is the role of pulmonary rehabilitation in COPD management?

To increase quality of life and exercise capacity, particularly for patients with an MRC score > 2.

16
New cards

What is the significance of inhaled therapies in COPD treatment?

LABA and LAMA improve FEV1 and symptoms; LAMA is superior in reducing exacerbations.

17
New cards

What is the purpose of the ABE Assessment Tool?

To categorise patients based on symptom burden and exacerbation history.

18
New cards

What is an exacerbation in the context of COPD?

An acute worsening of respiratory symptoms that requires additional therapy.

19
New cards

What are common causes of COPD exacerbations?

Respiratory tract infections are the most common causes.

20
New cards

What is the importance of inhaler technique in COPD management?

Over 90% of patients cannot use an MDI effectively; proper technique is crucial for medication efficacy.

21
New cards

What is the adherence rate for patients with long-term conditions like COPD?

Adherence rates range from 30-50%.

22
New cards

What is the role of pharmacists in COPD management?

Pharmacists assess non-adherence and help ensure proper inhaler use.

23
New cards

What is the impact of vaccinations on COPD patients?

Vaccinations, such as annual influenza and pneumococcal vaccines, decrease hospital admissions and mortality.

24
New cards

What is the recommended oxygen therapy duration for severe COPD?

Minimum of 15 hours/day for maximal benefits, ideally 20 hours/day.

25
New cards

What is the purpose of mucolytics in COPD treatment?

To reduce sputum viscosity and aid expectoration.

26
New cards

What are the benefits of LABA + LAMA combinations?

Cost-effective, maximize bronchodilation effects, and reduce exacerbations compared to monotherapy.

27
New cards

What additional therapies can reduce COPD exacerbations?

Roflumilast (PDE4 inhibitor) and Azithromycin (for non-current smokers).

28
New cards

What is the significance of identifying COPD phenotypes?

Helps tailor personalized treatment based on symptoms, exacerbation frequency, and response to therapy.

29
New cards

What is the relationship between smoking pack years and COPD risk?

The risk of developing COPD is dose-related and influenced by the age at which smoking begins.